Expression of HIV-1 subtype CRF01_AE GP41 protein in E. coli and its application for detection of anti-HIV antibody in patient’s sera by Western blot and ELISA
Author affiliations
DOI:
https://doi.org/10.15625/1811-4989/9/1/1074Keywords:
HIV-1 subtype CRF01_AE, gp41, diagnostic kit, Western blot, ELISAAbstract
In this paper we report the results on expression and purification of envelop GP41 protein of HIV-1 subtype CRF01_AE and its application for detection of anti-HIV antibody in patient’s sera by Western blot and ELISA. A gene region coding for extracellular domain of GP41 protein was amplified by PCR, inserted into pET32a+ expression vector. The recombinant plasmid carrying gp41 gene were selected by restriction enzyme analysis and confirmed by DNA sequencing. As designed, the recombinant GP41 protein was fused to a 6 histidines and Theoredoxin (Trx) at its N-terminal and has a molecular mass of approximately 37 kDa (6His-Trx-GP41). Recombinant GP41 was expressed as soluble form at 30oC and 0.5 mM IPTG with the expression yield of 20 mg/l culture medium. The recombinant protein was purified by affinity chromatography using ProBond Nickel-Chelating Resin (Invitrogen) under native condition, and was then used to detect anti-HIV antibody in patient’s sera by Western blot and ELISA. The Western blot results showed that recombinant GP41 reacted specifically with the antibody in HIV patient’s sera, especially it reacted more strongly with antibodies against HIV subtype CRF01_AE than that of HIV-1 subtype B. This data suggests the importance of development of HIV diagnostic kits base on antigens derived from subtypes circulating in the country.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Vietnam Journal of Biotechnology is a peer-reviewed, open access journal dedicated to the dissemination of scientific knowledge and research findings in the field of biotechnology. All published articles are freely accessible and downloadable by readers worldwide without any subscription or access fees.
All articles published in Vietnam Journal of Biotechnology are distributed under the terms of the Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) License. This license allows users to share, copy, redistribute, adapt, and reproduce the material in any medium or format, provided that appropriate credit is given to the original author(s) and source, and that any derivative works are distributed under the same license terms.
The copyright of each published article remains with the respective author(s) without restriction. By submitting and granting permission for publication through the journal’s submission system or other communication channels, authors authorize Vietnam Journal of Biotechnology to publish and identify itself as the original publisher of the work. Authors also acknowledge and agree to comply with the terms and conditions of the CC BY-SA 4.0 License and the policies established by the journal.
